Responsible for the medical strategy for the radioligand therapy (RLT) business and companion imaging kit in the indications GI-tumors, lung carcinoma, breast cancer and glioblastoma. Medical expert in the crossfunctional dossier core team for the German HTA process (AMNOG) and EMA submissions. Lead for the German integrated evidence squad having responsibility for the evidence needs in above RLT indications from Phase I to III as well as real-world evidence projects (e.g. chart reviews) to… Show more Responsible for the medical strategy for the radioligand therapy (RLT) business and companion imaging kit in the indications GI-tumors, lung carcinoma, breast cancer and glioblastoma. Medical expert in the crossfunctional dossier core team for the German HTA process (AMNOG) and EMA submissions. Lead for the German integrated evidence squad having responsibility for the evidence needs in above RLT indications from Phase I to III as well as real-world evidence projects (e.g. chart reviews) to close identified data gaps. Show less

Contributed to the design and execution of brand strategic goals including medical budget overview to allow for efficient, scientifically adequate launch readiness of lutetium (177Lu) vipivotide tetraxetan (Pluvicto) and gallium (68Ga) gozetotide (Locametz). Setup of an early access programme for Pluvicto in Germany. Responsible for the medical aspects of the HTA dossier (AMNOG, G-BA) for Pluvicto. Scientific input to the local publication strategy and planning. This includes developing the… Show more Contributed to the design and execution of brand strategic goals including medical budget overview to allow for efficient, scientifically adequate launch readiness of lutetium (177Lu) vipivotide tetraxetan (Pluvicto) and gallium (68Ga) gozetotide (Locametz). Setup of an early access programme for Pluvicto in Germany. Responsible for the medical aspects of the HTA dossier (AMNOG, G-BA) for Pluvicto. Scientific input to the local publication strategy and planning. This includes developing the medical pre- and post-launch narrative, the communication strategy, and leading the development of assets to support data roll-out and creation of scientific MSL materials. Review of investigator-initiated trial (IIT) proposals from a scientific and strategic perspective. Crossfunctional collaboration with Clinical Development, Clinical Operations, Pharmacovigilance and Epidemioloy for the setup of company-sponsored clinical trials spanning phase I to III. Show less

Medical expert for radionuclide therapy and molecular imaging (neuroendocrine tumours and prostate cancer) in Germany/Austria and the medical lead within the brand team. In this role, I supported the General Manager of AAA Germany/Austria and the Global Head of Medical Affairs with regards to the medical brand strategy. Close collaboration with commercial colleagues to provide scientific input for the development and review of promotional materials. Contact point for patient advocacy groups.

In this role, I support the team at AAA Germany/Austria regarding ethics, risks and compliance (ERC) and act as a liaison to the global ERC functions. This includes helping employees comply with all SOPs, internal policies, procedures and industry standards, rolling out new compliance standards, systems and trainings at local level, discussing compliance issues with management and employees and supporting global ERC in conducting periodic internal reviews.

Responsible for the peptide receptor radionuclide therapy of lutetium (177Lu) oxodotreotide (Lutathera) and its companion diagnostic gallium (68Ga) edotreotide (SomaKit TOC) for neuroendocrine tumours in Germany and Austria. Key responsibilities included setting up trusted relationships with key opinion leaders in medical oncology and nuclear medicine. Regular communication and scientific exchange with experts in the therapeutic area. Customer-focused preparation and presentation of new… Show more Responsible for the peptide receptor radionuclide therapy of lutetium (177Lu) oxodotreotide (Lutathera) and its companion diagnostic gallium (68Ga) edotreotide (SomaKit TOC) for neuroendocrine tumours in Germany and Austria. Key responsibilities included setting up trusted relationships with key opinion leaders in medical oncology and nuclear medicine. Regular communication and scientific exchange with experts in the therapeutic area. Customer-focused preparation and presentation of new clinical data. Organisation and execution of scientific events such as roundtables, advisory boards and medical symposia. Gathering of medical insights for the crossfunctional team as well as point of contact for sales representatives regarding medical information including training. Show less

Similar to the below Editor role including the following additional responsibilities:• Involved in cross-business projects which included working with external consultants on the development of research data products. • Selected to work on a high profile project looking into the optimisation of the manuscript lifecycle for 65 journals directly affecting 47 in-house editors. This included a problem analysis, incorporating feedback from stakeholders, developing optimisation strategies… Show more Similar to the below Editor role including the following additional responsibilities:• Involved in cross-business projects which included working with external consultants on the development of research data products. • Selected to work on a high profile project looking into the optimisation of the manuscript lifecycle for 65 journals directly affecting 47 in-house editors. This included a problem analysis, incorporating feedback from stakeholders, developing optimisation strategies and success measures, securing agreement from management/affected teams, testing and implementation.• Providing guidance and leadership to less experienced editors. This included resource planning, setting objectives, providing motivation and task ownership to improve performance and work satisfaction while meeting business goals.• Good understanding of market opportunities and threats as well as publishing industry trends. Developing successful business proposals such as a new and faster peer review workflow and driving to improve current working practices and technologies to grow the business. Show less

As Editor for the BMC series I was responsible for the strategic development of business priorities to grow a portfolio of biomedical, open access journals within their respective markets. This included monitoring key performance indicators, implementing innovative editorial board engagement strategies and building and managing relationships with authors, societies and the wider research community. The role required high standards of editorial judgement to make in-house decisions on… Show more As Editor for the BMC series I was responsible for the strategic development of business priorities to grow a portfolio of biomedical, open access journals within their respective markets. This included monitoring key performance indicators, implementing innovative editorial board engagement strategies and building and managing relationships with authors, societies and the wider research community. The role required high standards of editorial judgement to make in-house decisions on manuscripts, handle author misconduct cases and difficult ethics situations. I worked closely with colleagues in other departments such as marketing, production, operations and PR. Show less

As a physics lab demonstrator I assisted undergraduate students with their experiments, conducted oral exams, marked written lab reports and provided feedback. I gave tutorials on mathematical problem solving and worked as an assessor for the King’s Leadership Award.

Follow-up placement in a medical book department to understand the book publishing process where I also analysed sales data and conducted internet research.

Structured internship programme on medical journals introducing me to all editorial responsibilities such as author support, reviewing manuscripts, final corrections, conference visits, market research and writing content.